It is of note that ATM KO did not significantly sensitize cells to PARPi in HEK293A cells, which is consistent with a recent report showing that ATM KO did not enhance PARPi efficacy in 3 prostate cancer cell lines (63). The gene discussed is ATM; the disease is prostate cancer.